Tag Archives: University of Bristol

No Safe or Protective Level of Alcohol Consumption? (BBC News / Lancet)

Posted on April 6, 2019 by Dementia and Elderly Care News

Summary Light-to-moderate drinking increases blood pressure and the risk of stroke. “I have always been reasonably convinced that moderate alcohol consumption was protective for cardiovascular disease, but now I am having my doubts”. Professor David Spiegelhalter: Winton Professor for the … Continue reading →

Posted in Acute Hospitals, BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Statistics, Stroke, Universal Interest | Tagged Alcohol, Alcohol Acetaldehyde and East Asian Flushing Syndrome, Alcohol Consumption, Alcohol Dehydrogenase (ADH), Alcohol-Attributable Deaths and Disease Burden, Alcohol-Related Deaths, Alcohol-Related Harm, Aldehyde Dehydrogenase (ALDH), Amenable Mortality, Attributable Disease Burden Due to Alcohol Use, Avoidable Mortality, Avoidable Premature Mortality, BBC Health News, Behavioural Risk Factors, British Heart Foundation, Cancer Research UK, Cardiovascular Disease, Cardiovascular Risk, Cardiovascular Risk Factors, Cardiovascular Risk Factors (CVRF), China, China Kadoorie Biobank, Chinese Academy of Medical Sciences, Chinese Academy of Medical Sciences (Beijing), Chinese Ministry of Science and Technology, Clinical Trial Service Unit and Epidemiological Studies Unit: University of Oxford, Common Genetic Variants in East Asian Populations (ALDH2-rs671 and ADH1B-rs1229984), Department of Epidemiology and Biostatistics: Peking University, Epidemiology, Epidemiology and Statistics, Gansu Provincial Center for Disease Control and Prevention (Lanzhou), Genetic Epidemiology, Genetic Epidemiology in East Asian Populations, Genetic Research, Genetic Risk Factors, Genotypic Determinants of Alcohol Intake, GlaxoSmithKline, Henan Center for Disease Control and Prevention (Zhengzhou), Kadoorie Charitable Foundation, Lancet, Lifestyle Risk Factors, Liuyang Center for Disease Control and Prevention (Changsha), Low Risk Drinking, Medical Research Council, Medical Research Council Integrative Epidemiology Unit: University of Bristol, Medical Research Council Population Health Research Unit: University of Oxford, Modifiable Risk Factors, Mortality Risk Factors, Nangang Center for Disease Control and Prevention (Harbin), National Natural Science Foundation of China, Nuffield Department of Population Health: University of Oxford, Overlapping Risk Factors, Oxford, Peking University, Peking University Health Science Center, Population Health, Population Health Sciences: University of Bristol, Prevention, Prevention Agenda, Professor Sir David Spiegelhalter: Winton Professor for the Public Understanding of Risk at University of Cambridge, Psychosocial and Lifestyle-Related Risk Factors, Public Health, Public Health Burden of Alcohol, Reducing Alcohol-Related Harm, Stroke Prevention, University of Bristol, University of Oxford, Vascular Risk Factors, Wellcome Trust, Zhejiang Provincial Center for Disease Control and Prevention (Hangzhou) | Leave a comment

NICE Guidance on Best Interests Decision-Making and Mental Capacity: Theory and Practice? (NICE / British Journal of Psychiatry)

Posted on October 15, 2018 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence (NICE) has released a guideline covering decision-making in adults, over 16 years of age, who may lack capacity. The aim to support people to exercise their own decision-making where they have the capacity, and … Continue reading →

Posted in NICE Guidelines, Universal Interest | Tagged Advance Care Planning (ACP), Best Interests Decision-Making, Bristol Medical School: University of Bristol, British Journal of Psychiatry, Decision-Making and Mental Capacity, Decision-Making and Mental Capacity: NICE Guideline NG108, Division of Psychiatry: University College London, Empowering Patients, Empowerment and Dementia, Engagement and Patient Preferences., Ethical Considerations, Ethical Dilemmas, Ethical Issues of Dementia Care, Health Services Research: University of Exeter Medical School, Involvement of Patients With Dementia in Decisions on Medication Prescription, Involvement of Patients With Dementia in Decisions to Initiate Pharmacological Treatments, Lack of Empowerment, Later Life, Learning Disabilities, Medication Decisions in Dementia, Medication Decisions in Dementia: Assertions, Medication Decisions in Dementia: Offers, Medication Decisions in Dementia: Pronouncements, Medication Decisions in Dementia: Proposals, Medication Decisions in Dementia: Suggestions, Memory Clinics, Mental Health and Illness, National Institute for Health and Care Excellence (NICE), Neurological Disorders, Patient Acceptance, Patient Empowerment, Patient Involvement, Patient Preferences, Patient Satisfaction, Population Health Sciences: University of Bristol, SDM: Shared Decision Making, Shared Decision-Making, Supporting Decision-Making, Thinking Ahead - Advance Care Planning, Treatment Recommendation Coding Scheme, University College London, University of Bristol, University of Exeter, University of Exeter Medical School, Video-Recorded Dementia Diagnostic Meetings | Leave a comment

Cardiovascular Health in Old Age Associated With Reduced Risk of Cognitive Decline and Dementia (NHS Choices / JAMA)

Posted on August 27, 2018 by Dementia and Elderly Care News

Summary Fresh evidence from France suggests that favourable cardiovascular health metrics – measured using the American Heart Association (AHA)’s Life’s Simple 7 Metrics tool – and higher cardiovascular health scores, are associated with a lower risk of developing dementia and … Continue reading →

Reducing Health Inequalities and Premature Mortality for People With Learning Disabilities (BBC News / HQIP)

Posted on May 6, 2018 by Dementia and Elderly Care News

Summary The Healthcare Quality Improvement Partnership (HQIP) and the University of Bristol’s Norah Fry Research Centre have published an interim update report, commissioned by NHS England, on the premature deaths of people with learning disabilities in NHS care. The Learning … Continue reading →

Approaches to the Reduction of Preventable Hospital Admissions: a Systematic Review (BMJ Open)

Posted on August 10, 2017 by Dementia and Elderly Care News

Summary A recent systematic review examined the alternatives to hospital admission for older patients at risk of unplanned hospitalisation. The broad categories of interventions considered were (i) improved use of paramedic / emergency care practitioners, (ii) interventions based in emergency … Continue reading →

Development of Standardised Intervention Outcome Measures for Dementia Prevention (PLoS One / HTA)

Posted on July 25, 2017 by Dementia and Elderly Care News

Summary The following articles present work towards establishing a consensus on the most suitable outcomes to be measured when assessing “disease modification” (or the lack of it) in response to interventions intended to delay or prevent the progress of dementia. … Continue reading →

Posted in Alzheimer's Society, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Mental Health, Models of Dementia Care, Quick Insights, Standards, Systematic Reviews, UK | Tagged Activities of Daily Living (ADLs), Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Alzheimer's Society, Alzheimer’s Disease Clinical Trials, and Health Psychology: University College London, Assessment of Quality of Life, Aston Research Centre for Healthy Ageing: Aston University, Aston University, Bangor University, Biological Markers, Biomarkers, Brighton and Sussex Medical School, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Cardiff University, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Public Health: Queen's University Belfast, Centre for Research in Primary and Community Care: University of Hertfordshire, Clinical Dementia Rating (CDR), Clinical Dementia Rating Scale, Core Outcome Measures in Effectiveness Trials, Dementia Quality of Life (DEMQOL), Dementia Quality of Life Measure, Dementia Services Development Centre Wales: Bangor University, Department of Psychiatry and Psychotherapy: Ludwig-Maximilians-Universität München, Department of Psychiatry and Psychotherapy: Technische Universität München, Department of Psychiatry: University of Cambridge, Disability Assessment for Dementia-DAD, Disease Modification, Disease Modification Trials, Disease-Modifying Trials in Mild-to-Moderate Dementia, Division of Psychiatry: University College London, Division of Psychology and Language Sciences: University College London, Drug Trials Failure Rate, Faculty of Health and Social Care: University of Hull, Faculty of Medicine: Imperial College London, Germany, Health Technology Assessment (HTA) Programme, Health Technology Assessment Study, Health Technology Assessments, Imperial College London, Institute of Brain Behaviour and Mental Health: University of Manchester, Institute of Health and Society: Newcastle University, Institute of Mental Health: University of Nottingham, International Consortium for Health Outcomes Measurement, Kings College London, Leeds Beckett University, Ludwig-Maximilians-Universität München, Magnetic Resonance Imaging (MRI), Measurement of Successes and Failures of Dementia Treatments, Measuring the Impact of Interventions to Reduce Alzheimer’s Disease, Mini Mental State Examination (MMSE), National Institute for Health Research (NIHR), National Institute for Health Research: Health Technology Assessment Programme, Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory (NPI) Agitation / Aggression Scale, Neuropsychiatric Inventory Agitation / Aggression Domain (NPI), Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuroscience Research Centre - St. George's: University of London, Newcastle University, NIHR Health Technology Assessment (HTA) Programme, NIHR HTA: Health Technology Assessment Programme, North Thames CLAHRC, Norwich Medical School: University of East Anglia, Nuffield Department of Population Health: University of Oxford, Opportunities for Standardisation, Outcome Measures for Disease-Modifying Trials in Mild-to-Moderate Dementia, Outcome Validation, Oxford Health NHS Foundation Trust, Patient and Public Involvement (PPI), PenCLAHRC: University of Exeter Medical School, Personal Social Services Research Unit: University of Manchester, Potential Treatment for Alzheimer’s Disease, Queen's University Belfast, Research Department of Clinical Educational, Research Institute for the Care of Older People (RICE): University of Bath, ScHARR: University of Sheffield, School of Clinical Sciences: University of Bristol, School of Health and Community Studies: Leeds Beckett University, School of Healthcare Sciences: Cardiff University, School of Medicine: University of Southampton, School of Psychology: University of Exeter, School of Public Health: Imperial College London, sMRI (Structural Magnetic Resonance Imaging), Standardisation, Systematic Reviews and Meta-Analyses, Technische Universität München, United Kingdom, University College London, University of Bath, University of Bristol, University of Cambridge, University of East Anglia, University of Exeter, University of Exeter Medical School, University of Hertfordshire, University of Hull, University of London, University of Manchester, University of Nottingham, University of Oxford, University of Sheffield, University of Southampton, University of Warwick, Warwick Clinical Trials Research Unit: University of Warwick, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

MRC DRI Momentum Awards £4.3 Million For UK Dementia Research (MRC)

Posted on October 25, 2016 by Dementia and Elderly Care News

Summary Momentum Awards, which support the UK Dementia Research Institute (DRI). Today’s announcement involves six universities being awarded £4.3 million from the MRC to help develop UK-based dementia research. Judging from the press release, there appears to be a serious … Continue reading →

Posted in Commissioning, For Researchers (mostly), In the News, National, Quick Insights, UK, Universal Interest | Tagged Autism, Autism Spectrum Disorder (ASD), Biomarkers, Biomarkers Research Programmes, Bioscience Careers, Cardiff University, Computational Approaches to Discovery of Behavioural Signatures, Cross-Disciplinary Interfaces Exploring Emerging Scientific Opportunities, Dementia Research, Dementia Research Careers, Dementia Research Institute (DRI), Dr Kathryn Adcock: Head of Neurosciences and Mental Health at MRC, Epilepsy, Frontiers in Neuroscience, High Risk-High Payoff Research Projects (sic) [For Whom?], Human Brain Cell Types, Immune Pathways and Stem Cell (iPSC) Models of Neurodegenerative Disease, Institute of Psychiatry Psychology and Neuroscience (IoPPN), Kings College London, Maurice Wohl Clinical Neuroscience Institute, Momentum Awards, MRC Centre for Neurodevelopmental Disorders (King’s College London), MRC DRI Momentum Awards, MRC: Medical Research Council, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neurodevelopmental Disorders: Abnormal Brain Development, Neuroinflammation, Neuroinflammation Research Cluster, Neuroscience, Neurovascular Dysfunction, Potential Drug Targets, Professor Oscar Marín: Director of Department of Developmental Neurobiology at Institute of Psychiatry Psychology and Neuroscience (IoPPN), Proteostasis, Proteostasis Dysfunction, Pump-Priming (Dementia Research), Recruitment of Research Leaders / Rising Stars, Research and Development, Research and Innovation, Research Careers, Research Commitment, Research Culture, Research Funding, Schizophrenia, Sensor Platform for Healthcare in a Residential Environment (SPHERE), Signalling Pathways, Treatment and Prevention Targets, UK Dementia Research Institute, University of Bristol, University of Edinburgh, University of Manchester, University of Oxford | Leave a comment

Tag Archives: University of Bristol

NICE Guidance on Best Interests Decision-Making and Mental Capacity: Theory and Practice? (NICE / British Journal of Psychiatry)

Cardiovascular Health in Old Age Associated With Reduced Risk of Cognitive Decline and Dementia (NHS Choices / JAMA)

MRC DRI Momentum Awards £4.3 Million For UK Dementia Research (MRC)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites